Abstract:Stevens-Johnson Syndrome (SJS) constitutes a rather uncommon, and rarely fatal hypersensitivity reaction that primarily impacts the skin and mucous membranes and in certain cases may be attributed to drug administration. The aim of this article is to present a case of etoricoxib-induced SJS in a 46-year-old, female patient. The patient presented herself, as a medical emergency, to the Department of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, Greece, reporting pain, especially acute pain while eating certain foods, discomfort, dysphagia, and a wound in the left half of the hard palate. The clinical examination revealed a broad ulcer, in the left half of the hard palate as well as multiple ulcerations and erosions in the upper and lower lip. Her medical history was clear; however, the patient mentioned to have received etoricoxib, due to severe back pain, one day prior to our clinical examination. The patient received methylprednisolone 16 mg, twice per day, for two days, followed by methylprednisolone 8 mg, twice per day, for two more days. Her symptoms resigned and since the connection between etoricoxib and SJS was established, the patient was advised to avoid etoricoxib and be wary of adverse effects, when taking drugs especially non-steroidal anti-inflammatory medication. This is one of the first case reports in the literature, linking etoricoxib administration with the emergence of SJS, highlighting the importance of pharmacovigilance. The up-to-date registration of drug-induced adverse effects is of immense importance to protect future patients. SJS does not have a defined treatment strategy. Therefore, most patients are given supportive care and symptomatic treatment, which most commonly involves corticosteroids and antivirals such as acyclovir.

Fixed drug eruption secondary to etoricoxib

An Unusual Case Report and Review of the Literature

Chlorzoxazone-Induced Fixed Drug Eruption: A Clinical Case Report

Bullous Drug Eruption

Fixed Drug Eruption on the Penis Due to Trimethoprim-Sulfamethoxazole: A Case Report

Cross‐reactivity between Nonsteroidal anti‐inflammatory drugs in Fixed drug eruption: two unusual cases and a literature review

Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature

Annular drug eruptions

Generalized Fixed Drug Eruptions Require Urgent Care: A Case Series

Oral fixed drug eruption: Analyses of reported cases in the literature

Fixed Drug Eruption in a Patient of HLA-B*58:01 Negative after Allopurinol Administration: A Case Report

Fixed drug eruption due To 2,3-dimercapto-1-propanesulfonic acid (DMPS) treatment for mercury poisoning: a rare adverse effect

Cefditoren pivoxil induced toxic epidermal necrolysis: a case report

Fixed drug eruptions on male genitalia: clinical and etiologic study

The Occurrence of Etoricoxib-Induced Stevens-Johnson Syndrome With Oral Manifestations in a Female Patient: A Case Study

Enfortumab Vedotin Drug Eruption: Cutaneous Adverse Events and Histopathologic Findings

Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature

Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review

Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease

DRESS syndrome following furosemide administration: An unusual association

Purulent Bullous Epidermal Necrolysis: A Potential New Clinical Pattern of Drug Eruption